Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06595394 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Combined Exercise Training in Patients With Multiple Sclerosis

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Jan 2025 to Jun 30, 2026 Show 7 more changesShow less
    • Study completion date changed from estimate of Feb 2025 to Aug 29, 2026
    • Completed without a posted recruiting period
    • Enrollment target: estimated 30 to confirmed 28
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2024 to Oct 1, 2024
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 7 of 7 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this clinical trial is exercise in sarcopenic MS patients to demonstrate the effectiveness of education. The main questions it aims to answer are: -Can exercise training make a change in muscle thickness in sarcopenic MS patients? --Does exercise training have an effect on balance in sarcopenic MS patients? \- Does exercise training have an effect on the risk of falling in sarcopenic MS patients? Participants will: They will continue combined exercise applications 3 days a week for 8 weeks. Evaluations will be made before the application and at the end of the 8 weeks. The data will be analyzed afterwards.
Trial Details
NCT Number NCT06595394
Lead Sponsor Uskudar University
Conditions
(from sponsor)		 Multiple Sclerosis
Related terms Motor Activity, Multiple Sclerosis, Sarcopenia
Enrollment 28 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov